Kento Health
Founded 2022 · 15 employees on LinkedIn · 4 known investors
Kento provides a continuous cardiovascular monitoring and management platform that combines AI-powered risk scoring with clinical expertise to enable proactive heart care for hospitals, insurers, and patients. The platform captures real-time vitals and behavioral signals to predict and prevent adverse cardiac events.
Also known as Kento
Investors · 4
Company profile
researched Aug 2026Kento Health offers a cardiovascular care platform that combines continuously captured patient signals with AI-based analysis and clinician oversight. The system ingests vitals, wearable data, reported symptoms and behavioral information on an ongoing basis rather than only at scheduled appointments, and applies proprietary risk scoring and prediction that adapts daily to translate those signals into recommended next steps.
The product has two main surfaces: a patient application that delivers a daily care plan, specific actions and coaching that adjusts to incoming signals, and a clinician platform that surfaces prioritized insights and supports triage of patients by risk level and trend. Kento positions the platform across the full spectrum of cardiovascular conditions and care stages, including hypertension, high cholesterol, coronary artery disease, heart failure, atrial fibrillation, cardiomyopathy, peripheral artery disease, stroke, cardio-oncology support and post-procedure care following stents, valves and transplants.
Business model
Kento sells a SaaS platform to hospitals that embeds into existing clinical workflows, and offers insurers a turnkey model intended to prevent costly cardiac events through continuous monitoring and proactive support. Patients access daily adaptive support delivered through the app and supported by clinicians.
Traction
The company states its approach has been validated with leading U.S. health systems and published in peer-reviewed journals, and reports 75% fewer readmissions, 93% blood pressure control and a Net Promoter Score of 96.
▸Full profile — market position, technology, go-to-market
Market position
Kento frames its approach as predictive and continuous rather than episodic and reactive, pairing algorithmic risk prediction with human clinical expertise and coaching, and covering prevention, active management and long-term follow-up within a single platform.
Technology
Continuous data capture from vitals, wearables, symptom reports and behavioral inputs feeds Kento Intelligence, a proprietary risk-scoring and prediction layer with daily adaptation that converts raw signals into recommended clinical or patient actions. The output is delivered through a patient-facing app and a clinician-facing platform with risk- and trend-based triage.
Go-to-market
Direct offerings segmented by buyer: a SaaS deployment for hospitals integrated into clinical workflows, a turnkey program for insurers, and a consumer-facing patient app backed by clinicians.
Hospitals and health systems, insurers, and patients living with or at risk of cardiovascular conditions.
Compiled by commissioned research from 1 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
▸Research sources · 1
primary sources listed
- Kento Healthkentohealth.com · web
1 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Kento Health do?
- Kento Health runs an AI and clinician-supported platform for continuous cardiovascular monitoring and care.
- Who are Kento Health's investors?
- Kento Health's investors include Amplify Capital, Boreal Ventures, Broom Ventures, Graphite Ventures.